The fact AHZ could not reach anything like their projected market shows that trying to go it alone is extremely difficult . A company can have one of the best products in the world but trying to market one or two products by yourself world wide with limited capital is almost impossible . WP obviously had little choice , AHZ had the developed product but no way to get the exposure it needed to advance CardioCel and VascuCel so future ADAPT products including the TAVR would get recognition . Investors need to realise the type of salesmen needed to market these products are not going to be cheap as their Medical knowledge required would justify high wages . Really it would have been great if AHZ could have held both these products as ultimately they would have a range of ADAPT products which could justify a large sales team world wide Unfortunately it wasn’t to be but IMO WP has done a great job saving this company from almost certain bankruptcy . As I stated in previous posts IMO the vaccine section is what ultimately attracted investors but ultimately nearly lead to the company’s downfall . IMO AVR is on track to show investors the returns they assumed they would receive back in the early days of AHZ . Vaccines are always very risky and there was way to much hype generated by Frazers previous success . GLTATH
- Forums
- ASX - By Stock
- AVR
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-114
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $351.9M |
Open | High | Low | Value | Volume |
$18.80 | $19.15 | $18.20 | $159.7K | 8.611K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 73 | $18.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.33 | 90 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150 | 18.100 |
1 | 100 | 18.050 |
1 | 250 | 18.010 |
2 | 2010 | 18.000 |
1 | 55 | 17.910 |
Price($) | Vol. | No. |
---|---|---|
19.000 | 500 | 1 |
20.000 | 2950 | 4 |
20.120 | 420 | 1 |
20.200 | 309 | 1 |
20.400 | 678 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online